Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEE011 versus placebo in relapsed/refractory teratoma (phase II)
2014-000428-12Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in teratoma comparing LEE011 with Placebo (2 arms). Primary endpoint: Progression-free survival. Started Aug 2014; status: completed.
02
Drugs
ribociclib
03
Conditions
teratoma
Beyond the preview
Go deeper on 2014-000428-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000428-12.